Spinal interleukin-1β reduces inflammatory pain

Pain

Volumn 86, Issue 1-2, 2000, Pages 63-68

  Souter, Andrew J ^a   Garry, Mary G ^b  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antinociception; Inflammation; Interleukin 1 ; Intrathecal

Indexed keywords

NALOXONE; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 1BETA; BLOCKING ANTIBODY; CARRAGEENAN; INTERLEUKIN 1; NARCOTIC ANTAGONIST;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; MYELITIS; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; INFLAMMATION; INTRASPINAL DRUG ADMINISTRATION; PAIN; PAIN ASSESSMENT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTIBODIES, BLOCKING; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INJECTIONS, SPINAL; INTERLEUKIN-1; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0034178254     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00315-2     Document Type: Article

References (33)

1. Aldskogius H., Kozlova E.N. Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol. 55:1998;1-26.
2. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 542:1991;330-335.
3. DeLeo J.A., Colburn R.W., Ricknian A.J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759:1997;50-57.
4. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res. 30:1995;125-130.
5. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 334:1988;698-700.
6. Follenfant R.L., Nakamura-Craig M., Henderson B., Higgs G.A. Inhibition by neuropeptides of interleukin-1β-induced prostaglandin-independent hyperalgesia. Br J Pharmacol. 98:1989;41-43.
7. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. 657:1994;133-140.
8. Garry M.G., Hargreaves K.M. Enhanced release of immunoreactive CGRP and substance P from spinal dorsal horn slices occurs during carrageenan inflammation. Brain Res. 582:1992;139-142.
9. Garry M.G., Richardson J.D., Hargreaves K.M. Carrageenan-induced inflammation alters the content of i-cGMP and i-cAMP in the dorsal horn of the spinal cord. Brain Res. 646:1994;135-139.
10. Hargreaves K.M., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
11. Jeanjean A.P., Moussaoui S.M., Maloteaux J.-M., Laduron P.M. Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience. 68:1995;151-157.
12. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
13. Maier S.F., Wiertelak E.P., Martin D., Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623:1993;321-324.
14. Malcangio M., Bowery N.G., Flower R.J., Perretti M. Effect of interleukin 1-β on the release of substance P from rat isolated spinal cord. Eur J Pharmacol. 299:1996;113-118.
15. McQuay H.J., Carrol D., Moore R.A. Post-operative orthopaedic pain: the effect of opiate premedication and local anesthetic blocks. Pain. 33:1988;291-295.
16. Nakamura H., Nakanishi K., Kita A., Kadokawa T. Interleukin-1 induces analgesia in mice by a central action. Eur J Pharmacol. 149:1988;49-54.
17. Oka T., Aou S., Hon T. Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats. Brain Res. 624:1993;61-68.
18. Oku R., Satoh M., Takagi H. Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci Lett. 74:1987;315-319.
19. Perkins M.N., Kelly D. Interleukin-1 beta-induced desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology. 33:1994;657-660.
20. Plata-Salaman C.R., Kelly G., Agresta C., Taylor K., Salzman S.K. Interleukin-1 beta enhances spinal cord blood flow after intrathecal administration in the normal rat. Am J Physiol. 269:(5 Pt 2):1995;R1032-R1037.
21. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.3. Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol. 115:1995;1265-1275.
22. 2 in the hyperalgesia induced by intraplantar injections of low doses of thymulin. Brain Behav Immun. 11:1997;185-200.
23. Schafer M., Carter L., Stein C. Interleukin 1β and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA. 91:1994;4219-4223.
24. Sellami S., de Beaurepairre R. Hypothalamic and thalamic sites of action of interleukin-1β on food intake, body temperature and pain sensitivity in the rat. Brain Res. 694:1995;69-77.
25. Streit W.J., Kincaid-Colton C.A. The brain's immune system. Sci Am. 273:1995;54-61.
26. Sweitzer S.M., Colburn R.W., Rutkowski M., DeLeo J.A. Acute peripheral inflammation induces moderate glial activation and spinal IL-1 beta expression that correlates with pain behavior in the rat. Brain Res. 22:1999;209-221.
27. Tadano T., Namioka M., Nakagawasai O., Tan-No K., Matsushima K., Endo Y., Kisara K. Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice. Life Sci. 65:1999;255-261.
28. Taupin V., Toulmond S., Serrano A., Benavides J., Zavala F. Increase in IL-6, IL-1, and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with ROS 4864, a peripheral -type (p site) benzodiazepine ligand. J Neuroimmunol. 42:1993;177-185.
29. Tiseo P.J., Yaksh T.L. Dose-dependent antagonism of spinal opioid receptor agonists by naloxone and naltrindole: additional evidence for delta-opioid receptor subtypes in the rat. Eur J Pharmacol. 236:1993;89-96.
30. Wang C.X., Olschowka J.A., Wrathall J.R. Increase of interleukin-1β mRNA and protein in the spinal cord following experimental traumatic injury in the rat. Brain Res. 759:1997;190-196.
31. Watkins L.R., Wiertelak E.P., Ooehler L.E., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
32. Watkins L.R., Martin D., Ukich P., Tracey K.J., Maier S.F. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain. 71:1997;225-235.
33. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.